BioVie Inc. (BIVI)
1.18
-0.15 (-11.28%)
At close: Mar 03, 2025, 3:59 PM
1.17
-0.83%
After-hours: Mar 03, 2025, 06:06 PM EST
BioVie Income Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 229.38K | 266.84K | 237.42K | 229.38K | 229.38K | 229.38K | 229.38K | 229.38K | 51.04K | n/a | n/a | n/a |
Gross Profit | -229.38K | -266.84K | -237.42K | -229.38K | -229.38K | -229.38K | -229.38K | -229.38K | -51.04K | n/a | n/a | n/a |
Operating Income | -32.18M | -45.08M | -27.25M | -138.05M | -2.69M | -2.5M | -2.37M | -1.55M | -432.03K | -233.38K | -322.38K | -70.06K |
Interest Income | 1.14M | 562.26K | 44.08K | 21.97K | 234.00 | 1.16K | 4.00 | 14.00 | 186.00 | 369.00 | 489.00 | 20.00 |
Pretax Income | -32.12M | -50.26M | -26.08M | -130.25M | -16.68M | -2.44M | -2.41M | -1.33M | -431.92K | -233.01K | -321.9K | -70.04K |
Net Income | -32.12M | -50.26M | -26.08M | -183.85M | -33.78M | -2.49M | -2.43M | -1.33M | -431.92K | -233.01K | -321.9K | -70.04K |
Selling & General & Admin | 8.85M | 11.55M | 9.77M | 4.64M | 1.31M | 1.26M | 1.77M | 857.88K | 343.09K | 229.18K | 272.97K | 70.06K |
Research & Development | 23.1M | 33.3M | 17.26M | 133.19M | 1.15M | 1.01M | 370.85K | 466.35K | 37.9K | 4.2K | 49.42K | n/a |
Other Expenses | n/a | 229.38M | 229.38K | 229.38K | 229.38K | 229.38K | 229.38K | 229.38K | 51.04K | 212.71K | 247.08K | n/a |
Operating Expenses | 31.95M | 45.08M | 27.25M | 138.05M | 2.69M | 2.5M | 2.37M | 1.55M | 432.03K | 233.38K | 322.38K | 70.06K |
Interest Expense | 2.89M | 4.3M | 2.16M | 559.46K | 4.77M | 273.00 | 40.96K | n/a | 81.00 | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.18M | 45.08M | 27.25M | 138.05M | 2.69M | 2.5M | 2.37M | 1.55M | 432.03K | 233.38K | 322.38K | 70.06K |
Income Tax | n/a | 4.3M | -3.29M | 559.46K | 4.77M | -51.4K | -1 | -222.93K | -105 | -369 | -489 | 20.00 |
Shares Outstanding (Basic) | 9.04M | 6.5M | 4.93M | 2.48M | 985.9K | 507.92K | 153.21K | 143.03K | 139.52K | 139.54K | 139.33K | 65.96K |
Shares Outstanding (Diluted) | 9.04M | 6.5M | 4.93M | 2.48M | 985.9K | 507.92K | 153.21K | 143.03K | 139.52K | 139.54K | 139.33K | 65.96K |
EPS (Basic) | -3.56 | -7.74 | -5.29 | -74.11 | -34.26 | -4.91 | -15.88 | -9.3 | -3.1 | -1.67 | -2.31 | -1.06 |
EPS (Diluted) | -3.56 | -7.74 | -5.29 | -74.11 | -34.26 | -4.91 | -15.88 | -9.3 | -3.1 | -1.67 | -2.31 | -1.06 |
EBITDA | -31.95M | -45.69M | -23.68M | -137.8M | -2.46M | -2.27M | -2.14M | -1.32M | -380.81K | -233.01K | -321.9K | 20.00 |
Depreciation & Amortization | 229.38K | 266.84K | 237.42K | 229.38K | 229.38K | 229.38K | 229.38K | 229.38K | 51.04K | 369.00 | 489.00 | 70.06K |